Latest Regional Growth News

Page 7 of 7
Zenith Minerals has secured Program of Work approval to launch a new drilling campaign at its Dulcie Far North gold project, following a 40% resource increase. The company is also advancing development studies and exploring multiple new regional gold targets.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Arizona Lithium has unveiled a detailed, phased development plan for its Prairie Lithium Project, aiming to become North America’s first commercial lithium brine producer. The company targets initial production in 2025 with a modest capital outlay and scalable expansion strategy.
Maxwell Dee
Maxwell Dee
6 Feb 2025
Cavalier Resources has successfully raised A$1.735 million through a rights issue, positioning the company to advance its Crawford Gold Project amid record gold prices and promising exploration results.
Maxwell Dee
Maxwell Dee
31 Jan 2025
archTIS Limited reported a 12% increase in annual recurring revenue to $4 million and achieved net positive cash flow from operations, while signing a binding term sheet to acquire Direktiv’s assets, signaling strategic growth in data-centric security.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.
Ada Torres
Ada Torres
30 Jan 2025
Streamplay Studio has completed its acquisition of North American indie game publisher Noodlecake Studios, marking a pivotal expansion in its gaming portfolio. The company also reported robust regional growth and a strong cash position, setting the stage for ambitious product launches and market penetration.
Sophie Babbage
Sophie Babbage
28 Jan 2025
Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.
Eva Park
Eva Park
22 Jan 2025
Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.
Ada Torres
Ada Torres
15 Jan 2025